The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Delivery of Therapeutic Proteins
Open accessAbstract
The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g., liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEGylation is widely used in such modification for the delivery of proteins/peptides into the human body.35”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,312
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,344
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,628
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Research works printed but not linked: 2
- Kinstler, 1999, N-terminally chemically modified protein compositions and methods, United States Patent 5985265
- Mundargi, 2008, Nano/micro technologies for delivering macro- molecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives, J Control Release, 125, 193, 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 534
Peptide and Protein-Based Therapeutic Agents∗
Joseph, M. A., Trinh, H. M., & Mitra, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42978-8.00007-3 · Cited by 37
Qiu, M., Zhang, Z., Wei, Y., Sun, H., Meng, F., Deng, C., & Zhong, Z. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b02868 · Cited by 37
Plant-Based Polysaccharides and their Health Functions
Arora, S., Singh, D. P., Rajput, A., Bhatia, A., Kumar, A., Kaur, H., Sharma, P., Kaur, P., Singh, S., Attri, S., et al. (2021) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v11i4.773 · Cited by 41
Su, Z., Dong, S., Chen, Y., Huang, T., Qin, B., Yang, Q., Jiang, X., & Zou, C. (2023) · Advanced Science · doi:10.1002/advs.202206213 · Cited by 34
mRNA delivery via non-viral carriers for biomedical applications
Shuai, Q., Zhu, F., Zhao, M., & Yan, Y. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121020 · Cited by 35
Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles
Gaudana, R., Khurana, V., Parenky, A. C., & Mitra, A. K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/458128 · Cited by 34
Sun, Y., Liu, Y., Liu, W., Lu, C., & Lei, W. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2014.11.022 · Cited by 35
Advances on the formulation of proteins using nanotechnologies
Santalices, I., Gonella, A., Torres, D., & Alonso, M. J. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.06.018 · Cited by 35
Kim, Y. B., Zhao, K. T., Thompson, D. B., & Liu, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-10828-3 · Cited by 34
Bao, X. M., Si, X., Ding, X., Duan, L., & Xiao, C. (2019) · Journal of Polymer Research · doi:10.1007/s10965-019-1953-8 · Cited by 34
Quazi, M. Z., & Park, N. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00021 · Cited by 33
Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists
Liu, T., Zhang, Y., Liu, Y., Wang, Y., Jia, H., Kang, M., Luo, X., Caballero, D., González, J., Sherwood, L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423668112 · Cited by 33
Methods for engineering therapeutic peptides
Li, Y., Clark, K. A., & Tan, Z. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.05.027 · Cited by 33
Inter-protein interactions govern protein loading into porous vaterite CaCO 3 crystals
Feoktistova, N. A., Георгиевна, Б. Н., Skirtach, A. G., Volodkin, D. V., & Vikulina, A. S. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp00404a · Cited by 33
Ren, B.-J., Lu, J., Li, M., Zou, X., Liu, Y., Wang, C., & Wang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111171 · Cited by 33
Chiesa, E., Greco, A., Riva, F., Dorati, R., Conti, B., Modena, T., & Genta, I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101565 · Cited by 34
Capsosomes as Long-Term Delivery Vehicles for Protein Therapeutics
Maina, J. W., Richardson, J. J., Chandrawati, R., Kempe, K., van Koeverden, M. P., & Caruso, F. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01667 · Cited by 33
DeAngelis, P. L. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.978282 · Cited by 33
The biological efficacy profile of BAX 855, a PEG ylated recombinant factor VIII molecule
Valentino, L. A., Cong, L., Enockson, C., Song, X., Scheiflinger, F., Muchitsch, E. M., Turecek, P. L., & HAKOBYAN, N. (2014) · Haemophilia · doi:10.1111/hae.12532 · Cited by 32
Clements, A. E. B., & Murphy, W. L. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.04.051 · Cited by 32
Multicompartment Polymeric Nanocarriers for Biomedical Applications
Nayanathara, U., Kermaniyan, S. S., & Such, G. K. (2020) · Macromolecular Rapid Communications · doi:10.1002/marc.202000298 · Cited by 31
Li, Y., Li, P., Li, R., & Xu, Q. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000178 · Cited by 32
Glycosylated Enfuvirtide: A Long-Lasting Glycopeptide with Potent Anti-HIV Activity
Cheng, S., Chang, X., Wang, Y., Gao, G. F., Shao, Y., Ma, L., & Li, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5016582 · Cited by 32
Kapoor, S., Gupta, D., Kumar, M., Sharma, S., Gupta, A. K., Misro, M. M., & Singh, H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.077 · Cited by 32
Solomevich, S. O., Dmitruk, E. I., Bychkovsky, P. M., Salamevich, D. A., Kuchuk, S. V., & Yurkshtovich, T. L. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.200 · Cited by 31
Zou, A., Chen, Y., Huo, M., Wang, J., Zhang, Y., Zhou, J., & Zhang, Q. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23341 · Cited by 30
Immobilization of Actively Thromboresistant Assemblies on Sterile Blood‐Contacting Surfaces
Qu, Z., Krishnamurthy, V., Haller, C. A., Dorr, B. M., Marzec, U. M., Hurst, S., Hinds, M. T., Hanson, S. R., Liu, D. R., & Chaikof, E. L. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300110 · Cited by 30
Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation
Markwalter, C. E., Pagels, R. F., Hejazi, A. N., Gordon, A. G. R., Skowron, A., & Prud’homme, R. K. (2020) · The AAPS Journal · doi:10.1208/s12248-019-0405-z · Cited by 30
Essa, M. L., El-Kemary, M. A., Saied, E. M. E., Leporatti, S., & Hanafy, N. A. N. (2020) · Materials · doi:10.3390/ma13235397 · Cited by 30
Xu, W., He, X., Zhong, M., Hu, X., & Xiao, Y. (2014) · RSC Advances · doi:10.1039/c4ra08147a · Cited by 30
Critical attributes of formulation and of elaboration process of PLGA-protein microparticles
Martín‐Sabroso, C., Fraguas‐Sánchez, A. I., Aparicio-Blanco, J., Cano‐Abad, M. F., & Torres‐Suárez, A. I. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.008 · Cited by 30
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
Kuan, S. L., Fischer, S., Häfner, S., Wang, T., Syrovets, T., Liu, W., Tokura, Y., Ng, D. Y. W., Riegger, A., Förtsch, C., et al. (2018) · Advanced Science · doi:10.1002/advs.201701036 · Cited by 30
Optimization of PLGA formulation containing protein or peptide‐based antigen: Recent advances
Hajavi, J., Ebrahimian, M., Sankian, M., Khakzad, M. R., & Hashemi, M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36423 · Cited by 30
Shi, P., Qin, J., Hu, J., Bai, Y., & Zan, X. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.11.079 · Cited by 29
Salmaso, S., Bersani, S., Mastrotto, F., Tonon, G., Schrepfer, R., Genovese, S., & Caliceti, P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.018 · Cited by 29
Recent advances in oral delivery of peptide hormones
Varamini, P., & Tóth, I. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1142526 · Cited by 29
Chowdary, P. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.12.012 · Cited by 31
Aghaabdollahian, S., Cohan, R. A., Norouzian, D., Davami, F., Karam, M. R. A., Torkashvand, F., Vaseghi, G., Moazzami, R., & Dizaji, S. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39776-0 · Cited by 28
On-Demand and Tunable Dual Wavelength Release of Antibodies Using Light-Responsive Hydrogels
LeValley, P. J., Sutherland, B. P., Jaje, J., Gibbs, S. K., Jones, R. M., Gala, R. P., Kloxin, C. J., Kiick, K. L., & Kloxin, A. M. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00823 · Cited by 29
Arranz-Romera, A., Hernández, M., Checa-Casalengua, P., García‐Layana, A., Molina-Martínez, I. T., Recalde, S., Young, M. J., Tucker, B. A., Herrero‐Vanrell, R., Fernández‐Robredo, P., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14010050 · Cited by 28
Krobthong, S., Yingchutrakul, Y., Visessanguan, W., Mahatnirunkul, T., Samutrtai, P., Chaichana, C., Papan, P., & Choowongkomon, K. (2021) · Foods · doi:10.3390/foods10092157 · Cited by 28
The use and importance of liposomes in Positron Emission Tomography
Silindir‐Gunay, M., Özer, A. Y., & Erdoğan, S. (2012) · Drug Delivery · doi:10.3109/10717544.2011.635721 · Cited by 28
Yang, H. Y., Li, Y., Jang, M.-S., Fu, Y., Wu, T., Lee, J. H., & Lee, D. S. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.109342 · Cited by 27
Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease
Abasolo, I., Seras‐Franzoso, J., Moltó‐Abad, M., Díaz‐Riascos, V., Corchero, J. L., Pintos‐Morell, G., & Schwartz, S. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1684 · Cited by 27
Witeof, A. E., Daniels, A. L., Rea, L. T., Movafaghi, S., Kurtz, K., Davis, M. M., Eveland, R. W., Calderon, C. P., & Randolph, T. W. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.02.029 · Cited by 27
Biedulska, M., Jakóbczyk, P., Sosnowska, M., Dec, B., Muchlińska, A., Zaczek, A. J., Nidzworski, D., & Bogdanowicz, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-88791-7 · Cited by 27
LoPresti, C., Vetri, V., Ricca, M., Foderà, V., Tripodo, G., Spadaro, G., & Dispenza, C. (2010) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.11.030 · Cited by 27
A Drug Delivery System for Administration of Anti–TNF-α Antibody
Robert, M.-C., Frenette, M., Zhou, C., Yan, Y., Chodosh, J., Jakobiec, F. A., Stagner, A. M., Vavvas, D. G., Dohlman, C. H., & Paschalis, E. I. (2016) · Translational Vision Science & Technology · doi:10.1167/tvst.5.2.11 · Cited by 27
Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A
Unverdorben, F., Färber-Schwarz, A., Richter, F., Hutt, M., & Kontermann, R. E. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr061 · Cited by 29
Assessing microstructural critical quality attributes in PLGA microspheres by FIB-SEM analytics
Clark, A. G., Wang, R., Qin, Y., Wang, Y., Zhu, A., Lomeo, J., Bao, Q., Burgess, D. J., Chen, J., Qin, B., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.066 · Cited by 26
Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides
Lin, J., Yu, Z., & Gao, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c06851 · Cited by 28
Perspectives on dendritic architectures and their biological applications: From core to cell
Viswanath, V., & Santhakumar, K. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.05.023 · Cited by 26
Solid Lipid Nanoparticles: Peculiar Strategy to Deliver Bio-Proactive Molecules
Minocha, N., Sharma, N., Verma, R., Kaushik, D. K., & Pandey, P. (2022) · Recent Patents on Nanotechnology · doi:10.2174/1872210516666220317143351 · Cited by 26
Protein Nanocarriers for Targeted Drug Delivery for Cancer Therapy
Kariduraganavar, M. Y., Heggannavar, G. B., Amado, S., & Mitchell, G. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814033-8.00006-0 · Cited by 25
Intracellular Delivery of Functional Proteins with DNA–Protein Nanogels–Lipids Complex
Mariconti, M., Dechamboux, L., Heckmann, M., Gros, J., Morel, M., Escriou, V., Baigl, D., Hoffmann, C., & Rudiuk, S. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08000 · Cited by 25
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
Reuß, R. (2013) · Biologics · doi:10.2147/btt.s29948 · Cited by 25
Beyer, S., Xie, L., Schmidt, M., de Bruin, N. M. W. J., Ashtikar, M., Rüschenbaum, S., Lange, C. M., Vogel, V., Mäntele, W., Parnham, M. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.013 · Cited by 25
Comparative Study of In Situ Loaded Antibody and PEG‐Fab NIPAAM Gels
Awwad, S., Al-Shohani, A. D. H., Khaw, P. T., & Brocchini, S. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700255 · Cited by 25
Grafting challenging monomers from proteins using aqueous ICAR ATRP under bio-relevant conditions
Cohen-Karni, D., Kovaliov, M., Ramelot, T. A., Konkolewicz, D., Graner, S. R., & Averick, S. E. (2017) · Polymer Chemistry · doi:10.1039/c7py00669a · Cited by 24
Iyengar, A. R. S., Gupta, S., Jawalekar, S. S., & Pande, A. H. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257063 · Cited by 25
Fredenberg, S., Jönsson, M., Laakso, T., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.066 · Cited by 24
Leelawattanachai, J., Kwon, K.-W., Michael, P. L., Ting, R., Kim, J., & Jin, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124440 · Cited by 24
New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy
Theyab, A., Alsharif, K. F., Alzahrani, K. J., Oyouni, A. A. A., Hawsawi, Y. M., Algahtani, M., Alghamdi, S. A., & Alshammary, A. F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1026377 · Cited by 23
Kamei, N., Nielsen, E. J. B., Nakakubo, T., Aoyama, Y., Rahbek, U. L., Pedersen, B. L., & Takeda‐Morishita, M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.010 · Cited by 24
Newman, M. R., Russell, S. G., Schmitt, C. S., Marozas, I. A., Sheu, T., Puzas, J. E., & Benoit, D. S. W. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01193 · Cited by 23
Immunostimulatory biomaterials to boost tumor immunogenicity
Shofolawe-Bakare, O. T., Stokes, L. D., Hossain, M., Smith, A. E., & Werfel, T. A. (2020) · Biomaterials Science · doi:10.1039/d0bm01183e · Cited by 24
Protein-induced metamorphosis of unilamellar lipid vesicles to multilamellar hybrid vesicles
Koo, B. I., Kim, I., Yang, M. Y., Jo, S. D., Koo, K., Shin, S. Y., Park, K. M., Yuk, J. M., Lee, E. J., & Nam, Y. S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.004 · Cited by 22
Shah, N., Hussain, M., Rehan, T., Khan, A., & Khan, Z. U. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210910104333 · Cited by 22
Design Rules for the Sequestration of Viruses into Polypeptide Complex Coacervates
Joshi, P. U., Decker, C., Zeng, X., Sathyavageeswaran, A., Perry, S. L., & Heldt, C. L. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00938 · Cited by 22
Shi, K., Liu, Y., Ke, L., Fang, Y., Yang, R., & Cui, F. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.10.023 · Cited by 22
Brain delivery of proteins via their fatty acid and block copolymer modifications
Yi, X., & Kabanov, A. V. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.847098 · Cited by 22
Baier, G., Musyanovych, A., Landfester, K., Best, A., Lorenz, S., & Mailänder, V. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100003 · Cited by 22
Light-Controlled Release of Therapeutic Proteins from Red Blood Cells
Vickerman, B. M., O’Banion, C. P., Tan, X. M., & Lawrence, D. S. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01151 · Cited by 22
Spray-Drying of Biopharmaceuticals
Ledet, G. A., Graves, R. A., Bostanian, L. A., & Mandal, T. K. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2383-0_12 · Cited by 22
Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors
Weidle, U. H., Birzele, F., & Tiefenthaler, G. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20081 · Cited by 21
Bodenstine, T. M., Seftor, R. E. B., Seftor, E. A., Khalkhali‐Ellis, Z., Samii, N. A., Monarrez, J. C., Chandler, G. S., Pemberton, P. A., & Hendrix, M. J. C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0067 · Cited by 21
Peng, A., Kosloski, M. P., Nakamura, G., Ding, H. Y., & Balu‐Iyer, S. V. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9309-2 · Cited by 21
Self-citationErythrocyte‐mediated delivery of recombinant enzymes
Leuzzi, V., Rossi, L., Gabucci, C., Nardecchia, F., & Magnani, M. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9926-0 · Cited by 21
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Brekkan, A., Lázaro, L. L., Yngman, G., Plan, E. L., Acharya, C., Hooker, A. C., Kankanwadi, S., & Karlsson, M. O. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0249-y · Cited by 21
Wu, C., van de Weert, M., Baldursdóttir, S., Yang, M., & Mu, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.007 · Cited by 21
Muntimadugu, E., Silva-Abreu, M., Vives, G., Loeck, M., Pham, V., del Moral, M., Solomon, M. A., & Muro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074034 · Cited by 21
Mahbub, M. S. I., Sultana, T., Gwon, J., & Lee, B. (2021) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2021.1992877 · Cited by 20
Pamshong, S. R., Bhatane, D., Sarnaik, S., & Alexander, A. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113613 · Cited by 20
Ramos‐Espinosa, O., Hernández-Bazán, S., Francisco‐Cruz, A., Mata‐Espinosa, D., Barrios‐Payán, J., Marquina‐Castillo, B., López‐Casillas, F., Carretero, M., Río, M. D., & Hernández‐Pando, R. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw075 · Cited by 20
Kunjiappan, S., Panneerselvam, T., Somasundaram, B., Murugesan, S., Chowdhury, R., Chowdhury, A., & Bhattacharjee, C. (2017) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aaa1cf · Cited by 20
Gong, C., Zeng, J., Akinsanya, B., Jiang, H., Mora, J. R., Chilewski, S. D., Gambardella, J., Allentoff, A. J., Gleason, C. R., Aubry, A., et al. (2014) · Bioanalysis · doi:10.4155/bio.14.181 · Cited by 19
Gorth, D. J., Martin, J. T., Dodge, G. R., Elliott, D. M., Malhotra, N. R., Mauck, R. L., & Smith, L. J. (2014) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-014-0015-8 · Cited by 19
ATR-FTIR spectroscopy and spectroscopic imaging of proteins
Byrne, B., Beattie, J. W., Song, C. L., & Kazarian, S. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818610-7.00001-3 · Cited by 19
Ahanger, I. A., Ashraf, G. M., Sharma, A., & Islam, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230306085937 · Cited by 20
Characterization of extended channel bioreactors for continuous-flow protein production
Timm, A. C., Shankles, P. G., Foster, C. M., Doktycz, M. J., & Retterer, S. T. (2015) · Journal of Vacuum Science & Technology B Nanotechnology and Microelectronics Materials Processing Measurement and Phenomena · doi:10.1116/1.4932155 · Cited by 19
Chhabra, R., Grabrucker, A. M., Veratti, P., Belletti, D., Boeckers, T. M., Vandelli, M. A., Forni, F., Tosi, G., & Ruozi, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.054 · Cited by 19
Acylation of arginine in goserelin-loaded PLGA microspheres
Shirangi, M., Hennink, W. E., Somsen, G. W., & van Nostrum, C. F. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.11.008 · Cited by 19
Chang, P., Prestidge, C. A., Barnes, T. J., & Bremmell, K. E. (2016) · RSC Advances · doi:10.1039/c6ra16254a · Cited by 19
Sahoo, K. K., Karumuri, S., Koralege, R. S. H., Flynn, N. H., Hartson, S. D., Liu, J., Ramsey, J. D., Kalkan, A. K., Pope, C., & Ranjan, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00053 · Cited by 19
Li, Z., Xie, J., Peng, S., Liu, S., Wang, Y., Lu, W., Shen, J., & Li, C. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00326 · Cited by 19
Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy
Huang, H., Lin, Y., Jiang, Y., Yao, Q., Chen, R., Zhao, Y., & Kou, L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.12.012 · Cited by 18
Papadopoulou, L. C., & Tsiftsoglou, A. S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0546-y · Cited by 17
Catalase-Laden Microdevices for Cell-Mediated Enzyme Delivery
Xia, J., Wang, Z., Yan, Y., Cheng, Z., Sun, L. J., Li, Y., Ren, Y., & Guan, J. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b03160 · Cited by 18
Kangwa, M., Yelemane, V., Ponnurangam, A., & Fernández‐Lahore, M. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.11.003 · Cited by 18
Elucidating Molecular Design Principles for Charge-Alternating Peptides
Smith, J. K., McMullen, P., Yuan, Z., Pfaendtner, J., & Jiang, S. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01191 · Cited by 18
Metadata
- Authors
- Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V.
- Affiliations
- University at Buffalo, State University of New York (US)
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 99
- Issue
- 6
- Pages
- 2557-2575
- ISSN
- 0022-3549 (ISSN-L)
- PMC
- PMC2857543
- OpenAlex
- W1985516113
- Cited by
- 532
- References
- 160
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 38 · 2022: 25 · 2021: 31 · 2020: 42 · 2019: 44 · 2018: 45 · 2017: 43 · 2016: 48 · 2015: 40 · 2014: 48 · 2013: 26 · 2012: 28
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL070227, HL-70227)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- therapeutic proteins, drug delivery, protein stability, immunogenicity, protein half-life, PEGylation, polysialic acid, glycolic acid, nanoparticle drug delivery, liposomes, polymeric nanoparticles, polymer microspheres, colloidal drug delivery
- MeSH terms
- Chemistry, Pharmaceutical, Half-Life, Humans, Liposomes, Microspheres, Polyethylene Glycols, Polymers, Proteins, Sialic Acids, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review